| Don't Suffer with OCD |
Rebecca Shannonhouse |
2013 |
Mental Disorders |
| Gut feelings: the future of psychiatry may be inside your stomach |
Carrie Arnold |
2013 |
Mental Disorders |
| Usefulness of HPHPA marker in a wide range of neurological, gastrointestinal, and psychiatric disorders |
Shaw, William Ph.D |
2010 |
Mental Disorders |
| The Role of Cholesterol in Autism |
Shaw, William Ph.D |
- |
Mental Disorders |
| The Unique Vulnerability of the Human Brain to Toxic Chemical Exposure and the Importance of Toxic Chemical Evaluation and Treatment in Orthomolecular Psychiatry |
Shaw, William Ph.D |
2010 |
Mental Disorders |
| The Tomato Effect |
Greenblatt, James M.D. |
- |
Mental Disorders |
| National patterns in antidepressant medication treatment. |
Arch Gen Psychiatry, August, 2009 |
2009 |
Mental Disorders |
| Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. |
Madhukar, T., Am J Psychiatry. 2006; 163; 28-40 |
2006 |
Mental Disorders |
| Clinical features of treatment-resistant depression. |
Kornstein & Schneider. J Clin Psychiatry 2001 |
2001 |
Mental Disorders |
| The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. |
DeBattista, C., et al., J Psychiatric Res, 2010 |
2010 |
Mental Disorders |
| Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. |
Gesch, C.B., et al. (2002). British Journal of Psychiatry, 181, 22-28 |
2002 |
Mental Disorders |
| Science and society: Brain foods: the effects of nutrients on brain function |
Gómez-Pinilla, F. Nature Reviews Neuroscience 9, 568-578 (July 2008) |
2008 |
Mental Disorders |
| Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development.
|
Dolinoy, DC, D Huang and RL Jirtle. 2007. |
2007 |
Mental Disorders |
| Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome.
|
Dolinoy, et al., Environ Health Perspect, 2006 |
2006 |
Mental Disorders |
| Fooling Mother Nature: Epigenetics and novel treatments for psychiatric Disorders
|
Stahl, S. (2010). CNS Spectrum, 15(4): 220-230 |
2010 |
Mental Disorders |
| Omeprazole therapy causes malabsorption of cyanocobalamin (Vitamin B12)
|
Marcuard, S.P., et al. (1994). Ann Intern Med, 120:211-215 |
1994 |
Mental Disorders |
| What are the psychiatric manifestations of vitamin B12 deficiency?
|
Hector M, Burton JR. J Am Geriatr Soc. 1988 |
1988 |
Mental Disorders |
| Vitamin B12 levels are low in hospitalized psychiatric patients.
|
Silver H. Isr J Psychiatry Relat Sci, 2000 |
2000 |
Mental Disorders |
| Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from randomized, double-blind, placebo-controlled trial.
|
Laan, et al., J Clin Psychiatry, 2010 |
2010 |
Mental Disorders |
| Rapid recovery from major depression using Magnesium treatment. |
Eby E, Eby K, Medical Hypotheses, 2006 |
2006 |
Mental Disorders |
| Is it time to trial vitamin D supplements for the prevention of schizophrenia? |
McGrath, Acta Psychiatr Scand, 2010 |
2010 |
Mental Disorders |
| Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. |
Modai, et al., J Clin Psychiatry, 1994 |
1994 |
Mental Disorders |
| Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. |
Amminger, et al., Arch Gen Psychiatry, 2010 |
2010 |
Mental Disorders |
| Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. |
Humble, et al., J Steroid Biochem Mol Biol, 2010 |
2010 |
Mental Disorders |
| Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. |
Church, et al., J Neurol Neurosurg Psychiatry, 2003 |
2003 |
Mental Disorders |
| Identification of pyruvate kinase as an antigen associated with Tourette syndrome. |
Kansy, et al., J Neuroimmunol, 2006 |
2006 |
Mental Disorders |
| Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. |
Dale, et al., J Neuroimmunol, 2006 |
2006 |
Mental Disorders |
| A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. |
Perlmutter, et al., Am J Psychiatry, 1998 |
1998 |
Mental Disorders |
| Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumonia, and beta-hemolytic streptococci). |
Gluck, et al., Am J Nutr, 2003 |
2003 |
Mental Disorders |
| Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. |
Shaw, et al., Clin Chem, 1995 |
1995 |
Mental Disorders |
| Assessment of antifungal drug therapy in autism by measurement of suspected microbial metabolites in urine with gas chromatography-mass spectrometry. |
Shaw, et al., Clinical Practice of Alternative Medicine Magazine, 2000 |
2000 |
Mental Disorders |
| Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of clostridia spp. In the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. |
Shaw W. Nutr Neurosci, 2010 |
2010 |
Mental Disorders |
| Short-term benefit from oral vancomycin treatment of regressive-onset autism. |
Sandler, et al., J Child Neurol, 2000 |
2000 |
Mental Disorders |
| Research suggests link between pesticides and brain disease. |
Gunderson D. Minnesota Public Radio, 2006 |
2006 |
Mental Disorders |
| Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease. |
Guillemin and Brew. Redox Rep, 2002 |
2002 |
Mental Disorders |
| Long-term occupational exposure and the diagnosis of dementia. |
Freed and Kandel. Neurotoxicology. 1988 |
1988 |
Mental Disorders |
| Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. |
Kukull, et al., Am J Epidemiol, 1995 |
1995 |
Mental Disorders |
| Toxicant exposure and mental health-individual, social, and public health considerations. |
Genius SJ. J Forensic Sci, 2009 |
2009 |
Mental Disorders |
| Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. |
Sas, et al., J Neurol Sci, 2007 |
2007 |
Mental Disorders |
| Cognitive decline as a manifestation of mitochondrial disorders (mitochondrial dementia). |
Finsterer J. J Neurol Sci, 2008 |
2008 |
Mental Disorders |
| The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. |
Jahn, et al., Carbohydr Res, 1999 |
1999 |
Mental Disorders |
| Hyaluronidase and chondroitin sulphatase production by different species of Candida. |
Shimzu, et al., Medical Mycology, 1995 |
1995 |
Mental Disorders |
| Effectiveness of nystatin in polysymptomatic patients. A randomized, double-blind trial with nystatin versus placebo in general practice. |
Santelmann, et al., Fam Pract, 2001 |
2001 |
Mental Disorders |
| Function of dietary polyunsaturated fatty acids in the nervous system. |
Bourre, et al., Prostaglandins Leukot Essent Fatty Acids, 1993 |
1993 |
Mental Disorders |
| Natural Products in the Clinical Treatment of Mental Illness: A Profile of Dr. James Greenblatt, M.D. |
Leonard, Joe |
- |
Mental Disorders |
| ADHD |
Greenblatt, James M.D. |
- |
Mental Disorders |
| Nutritional Supplements in ADHD |
Greeblatt, James M.D., Letter to the Editor of J Am Acad Child Adolesc Psychiatry, 38:10, October 1999 |
1999 |
Mental Disorders |
| Nutritional Treatment for Attention Deficit Hyperactivity Disorder: The Hype and the Hope - A Review of Current Research |
Greenblatt, James M.D. and Gina L. Nick, Ph.D., N.D. |
- |
Mental Disorders |
| Oligomeric Proanthocyanidins as an Alternative Treatment for ADHD: A Case Study |
Greenblatt, James M.D. |
- |
Mental Disorders |
| Pycnogenol for ADHD? |
Steven W. Heimann, M.D., Letter to the Editor of J Am Acad Child Adolesc Psychiatry, 38:4, April 1999 |
1999 |
Mental Disorders |
| The Complete Assessment for Attention Deficit Hyperactivity Disorder |
Greenblatt, James M.D. |
- |
Mental Disorders |
| Low Cholesterol and Its Psychological Effects |
Greenblatt, James M.D., The Breakthrough Depression Solution, June 10, 2011 |
2010 |
Mood Disorders |
| The Depressing News About Antidepressants (PDF) |
Begley, S., Newsweek, February 8, 2010 |
2010 |
Mood Disorders |
| Rapid recovery from major depression using Magnesium treatment. |
Eby E, Eby K, Medical Hypotheses, 2006 |
2006 |
Mood Disorders |
| Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. |
Penninx, et al., Am J Psychiatry 2000 |
2000 |
Mood Disorders |
| The utility of laboratory screening in medically ill patients with psychiatric symptoms |
Catalano, et al., Annals of Clinical Psychiatry, 2001 |
2001 |
Mood Disorders |
| A routine CBC leads to a non-routine diagnosis |
Middleman and Melchiono, Adolesc Med, 1996 |
1996 |
Mood Disorders |
| A case of mania secondary to vitamin B12 deficiency |
Goggans, American Journal of Psychiatry, 1984 |
1984 |
Mood Disorders |
| T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression |
Huang and Lee, Psychiatry Clin Neurosci, 2007 |
2007 |
Mood Disorders |
| Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy |
Sutcigil, et al., Clin Dev Immunol, 2007 |
2007 |
Mood Disorders |
| The effects of tryptophan depletion on mood and psychiatric symptoms |
Van der Does, Journal of Affective Disorders, 2001 |
2001 |
Mood Disorders |
| Dietary tyrosine benefits cognitive and psychomotor performance during body cooling |
O'Brien, et al., Physiology & Behavior, 2007 |
2007 |
Mood Disorders |
| Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial |
Coppen and Bailey, Journal of Affective Disorders, 2000 |
2000 |
Mood Disorders |
| Folate, vitamin B12, and homocysteine in major depressive disorder |
Fava, et al., Am J Psychiatry, 1997 |
1997 |
Mood Disorders |
| Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. |
Papakostas, et al., J Clin Psychiatry, 2004 |
2004 |
Mood Disorders |
| Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. |
Gilbody, et al. J Epidemiol Community Health, 2007 |
2007 |
Mood Disorders |
| Folic acid and the treatment of depression. |
Abou-Saleh & Copper, J Psychosom Res, 2006 |
2006 |
Mood Disorders |
| Folate and colorectal cancer: an evidence-based critical review. |
Kim, Mol Nutr Food Res, 2007 |
2007 |
Mood Disorders |
| Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. |
Morris, et al., Arch Neurol, 2005 |
2005 |
Mood Disorders |
| Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. |
Dias, et al., J Affective Disorders, 2009 |
2009 |
Mood Disorders |
| S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. |
Papakostas, et al., Am J Psychiatry, 2010 |
2010 |
Mood Disorders |
| Zinc: the new antidepressant? |
Levenson, Nutr Rev, 2006 |
2006 |
Mood Disorders |
| Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. |
Nowak, Pol J Pharmacol, 2003 |
2003 |
Mood Disorders |
| Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. |
Siwek, et al., J Affect Disord, 2009 |
2009 |
Mood Disorders |
| Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's disease and Down syndrome. |
Jang, et al., Proc Natl Acad Sci USA, 2010 |
2010 |
Mood Disorders |
| Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. |
Stoll, et al., Arch Gen Psychiatry, 1999 |
1999 |
Mood Disorders |
| Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. |
Clayton, et al., Eur J Clin Nutr, 2009 |
2009 |
Mood Disorders |
| Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. |
Behzadi, et al., Acta Psychiatr Scand, 2009 |
2009 |
Mood Disorders |
| Successful treatment of bipolar disorder II and ADHD with micronutrient formula: a case study. |
Rucklidge and Harrison, CNS Spectr, 2010 |
2010 |
Mood Disorders |
| Effect of lithium maintenance on suicidal behavior in major mood disorders. |
Tondo, et al., Ann NY Acad Sci, 1997 |
1997 |
Mood Disorders |
| Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation. |
Basselin, et al., J Lipid Res, 2010 |
2010 |
Mood Disorders |
| Low serum cholesterol in suicide attempters. |
Kunugi, et al., Biol Psychiatry, 1997 |
1997 |
Mood Disorders |
| Association of low serum total cholesterol with major depression and suicide. |
Partonen, et al., Br J Psychiatry, 1999 |
1999 |
Mood Disorders |
| Low serum cholesterol and external-cause mortality: potential implications for research and surveillance. |
Boscarino, et al., J Psychiatr Res, 2009 |
2009 |
Mood Disorders |
| Low serum HDL-cholesterol levels are associated with long symptom duration in patients with major depressive disorder. |
Lehto, et al., Psychiatry Clin Neurosci, 2010 |
2010 |
Mood Disorders |
| Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. |
Nemets, et al., Am J Psychiatry, 2006 |
2006 |
Mood Disorders |
| Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial. |
Su, et al., Eur Neuropsychoparmacol, 2003 |
2003 |
Mood Disorders |
| Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial. |
Rondanelli, et al., J Am Coll Nutr, 2010 |
2010 |
Mood Disorders |
| Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. |
Sublette, et al., Am J Psychiatry, 2006 |
2006 |
Mood Disorders |
| Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents. |
Mamalakis, et al., Pharmacol Biochem Behav, 2006 |
2006 |
Mood Disorders |
| Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. |
Clayton, et al., Eur J Clin Nutr, 2009 |
2009 |
Mood Disorders |
| Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. |
Zanarini, et al., Am J Psychiatry, 2003 |
2003 |
Mood Disorders |
| Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. |
Bouchard, et al., Arch Gen Psychiatry, 2009 |
2009 |
Mood Disorders |
| The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. |
Dyck, et al., Eur J Pharmacol, 1982 |
1982 |
Mood Disorders |
| Chronic intestinal candidiasis as a possible etiological factor in the chronic fatigue syndrome. |
Cater RE, Med Hypotheses, 1995 |
1995 |
Mood Disorders |
| Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness. |
Evengard, et al., Scan J Gastroenerol, 2007 |
2007 |
Mood Disorders |
| Differential effects of cholesterol and 7-dehydrocholesterol on ligand binding of solubilized hippocampal serotonin1A receptors: implications in SLOS. |
Chattopadhyay, et al., Biochem Biophys Res Commun, 2007 |
2007 |
Mood Disorders |
| Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. |
Snellman, et al., PLoS One, 2009 |
2009 |
Mood Disorders |
| Association between low plasma levels of cholesterol and relapse in cocaine addicts. |
Buydens-Branchey L, Branchey M. Psychosom Med, 2003 |
2003 |
Mood Disorders |
| Omega-3 fatty acids in major depressive disorder |
Freeman MP. J Clin Psychiatry, 2009 |
2009 |
Mood Disorders |
| The efficacy of omega-3 supplementation for major depression: a randomized controlled trial |
Lesperance, et al., J Clin Psychiatry, 2010 |
2010 |
Mood Disorders |
| Beyond the Basics – New Approaches to Treatment of Anorexia Nervosa |
Greenblatt, James M.D., Chief Medical Officer, Walden Behavioral Care |
- |
Eating Disorders |
| Clinical Treatment of Anorexia Nervosa Merits More Attention |
Greenblatt, James M.D., Chief Medical Officer, Walden Behavioral Care |
- |
Eating Disorders |
| Excess mortality, causes of death and prognostic factors in anorexia nervosa. |
Papadopoulos, et al., Br J Psychiatry, 2009 |
2009 |
Eating Disorders |
| Three psychotherapies for anorexia nervosa: a randomized, controlled trial. |
McIntosh, et al., Am J Psychiatry, 2005 |
2005 |
Eating Disorders |
| A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. |
Holtkamp, et al., J Psychiatr Res, 2005 |
2005 |
Eating Disorders |
| Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. |
Walsh, et al., JAMA, 2006 |
2006 |
Eating Disorders |
| Puberty moderates genetic influence on disordered eating. |
Klump, et al., Psychol Med, 2007 |
2007 |
Eating Disorders |
| Zinc deficiency in anorexia nervosa. |
Katz, et al., J Adolesc Health Care, 1987 |
1987 |
Eating Disorders |
| Oral zinc supplementation in anorexia nervosa. |
Safai-Kutti, Acta Psychiatr Scand Suppl, 1990 |
1990 |
Eating Disorders |
| Zinc status before and after zinc supplementation of eating disorder patients. |
McClain, et al., J Am Coll Nutr, 1992 |
1992 |
Eating Disorders |
| Zinc deficiency and childhood-onset anorexia nervosa. |
Lask, et al., J Clin Psychiatry, 1993 |
1993 |
Eating Disorders |
| Controlled trial of zinc supplementation in anorexia nervosa. |
Birmingham, et al., Int J Eat Disord. 1994 |
1994 |
Eating Disorders |
| Anorexia nervosa responding to zinc supplementation: a case report. |
Yamaguchi, et al., Gastroenterol Jpn, 1992 |
1992 |
Eating Disorders |
| A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosa. |
Ayton, et al., Prostaglandins Leukot Essent Fatty Acids, 2004 |
2004 |
Eating Disorders |
| Eating disorders: hope despite mortal risk. |
Kaye, W. Am J Psychiatry, 2009 |
2009 |
Eating Disorders |
| A peptide found in schizophrenia and autism causes behavioral changes in rats. |
Sun, et al., Autism, 1999 |
1999 |
Eating Disorders |
| Urinary peptide levels in women with eating disorders. A pilot study. |
Hellzen, et al., Eat Weight Disord, 2003 |
2003 |
Eating Disorders |
| Double-blind, controlled trial of Inositol treatment of depression. |
Levine, et al., Am J Psychiatry, 1995 |
1995 |
Eating Disorders |
| Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. |
Benjamin, et al., Am J Psychiatry, 1995 |
1995 |
Eating Disorders |
| Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. |
Palatnik, et al., J Clin Psychopharmacol, 2001 |
2001 |
Eating Disorders |
| Inositol treatment of obsessive-compulsive disorder. |
Fux, et al., Am J Psychiatry, 1996 |
1996 |
Eating Disorders |
| Effect of Inositol on bulimia nervosa and binge eating. |
Gelber, et al., Int J Eat Disord, 2001 |
2001 |
Eating Disorders |
| Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. |
Cravchik A, Golman D. Arch Gen Psychiatry, 2000 |
2000 |
Eating Disorders |
| A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate the clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. |
Koetter, et al., Phytother Res, 2007 |
2007 |
Sleep Disorders |
| Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? |
Poyares, et al., Prog Neuropsychopharmacol Biol Psychiatry, 2002 |
2002 |
Sleep Disorders |
| Niacinamide's potent role in alleviating anxiety with its benzodiazepine-like properties: a case report. |
Prousky, JE, Orthomol Med, 2004 |
2004 |
Sleep Disorders |
| The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. |
Starobrat-Hermelin B, Kozielec T, Magnes Res, 1997 |
1997 |
Sleep Disorders |
| Reasons to Perform Total IgG Food Allergy Testing Instead of IgG4 Food Allergy Testing. |
Shaw, William Ph.D |
- |
Food Allergies |
| New insight into the solution structures of wheat gluten proteins from Raman optical activity. |
Blanch, et al., Biochemistry, 2003 |
2003 |
Food Allergies |
| Intestinal digestive resistance of immunodominant gliadin peptides. |
Hausch, et al., Am J Physiol Gastrointest Liver Physiol, 2002 |
2002 |
Food Allergies |
| Advances in celiac disease and gluten-free diet. |
Niewinski NM, J AM Diet Assoc, 2008 |
2008 |
Food Allergies |
| Gluten sensitivity as a neurological illness. |
Hadjivassiliou, et al., J Neurol Neurosurg Psychiatry, 2002 |
2002 |
Food Allergies |
| Frontal cortical perfusion abnormalities related to gluten intake and associated autoimmune disease in adult celiac disease: 99m Tc-ECD brain SPECT study. |
Usai, et al., Dig Liver Dis, 2004 |
2004 |
Food Allergies |
| Depression in adult untreated celiac subjects: diagnosis by the pediatrician. |
Corvaglia, et al., Am J Gastroenterol, 1999 |
1999 |
Food Allergies |
| Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. |
Maes, et al., Acta Psychiatr Scand, 1996 |
1996 |
Food Allergies |
| Lower activity of serum peptidases in abstinent alcohol-dependant patients. |
Maes, et al., Alcohol, 1999 |
1999 |
Food Allergies |
| Dipeptidyl peptidase IV and adenosine deaminase activity. Decrease in depression. |
Elgun, et al., Psychoneuroendocrinology, 1999 |
1999 |
Food Allergies |
| Autism and Schizophrenia: Intestinal Disorders |
Cade, et al., Nutritional Neuroscience, 2000 |
2000 |
Food Allergies |
| Beta-casomorphin induces fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism. |
Sun, et al., Autism, 1999 |
1999 |
Food Allergies |
| Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. |
Jyonouchi, et al., Neuropsychobiology, 2002 |
2002 |
Food Allergies |
| Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. |
Jelinkova, et al., FEBS Lett, 2004 |
2004 |
Food Allergies |
| Critical analysis of the diets of chronic juvenile offenders. |
Schauss, et al., J Orthomolecular Psychiatry, 1979 |
1979 |
Food Allergies |
| Higher plasma concentration of food-specific antibodies in persons with autistic disorder in comparison to their siblings. |
Trajkovski, et al., Focus on Autism, 2008 |
2008 |
Food Allergies |
| Food allergy and infantile autism. |
Lucarelli, et al., Panminerva Med, 1995 |
1995 |
Food Allergies |
| Neuropsychological dysfunction related to earlier occupational exposure to mercury vapor. |
Zachi, et al., Braz J Med Biol Res, 2007 |
2007 |
Toxic Chemicals |
| Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. |
Calderon-Garciduenas, et al., Toxicol Pathol, 2008 |
2008 |
Toxic Chemicals |
| An anthropological approach to the evaluation of preschool children exposed to pesticides in Mexico. |
Guillette, et al., Environ Health Perspect, 1998 |
1998 |
Toxic Chemicals |
| Medications as a source of human exposure to phthalates. |
Hauser, et al., Environ Health Perspect, 2004 |
2004 |
Toxic Chemicals |
| Origins of and Recognition of Micronutrient Deficiencies After Gastric Bypass Surgery |
Bal BS, et al., Curr Diab Rep., 2010 |
2010 |
Other |
| Dr. Greenblatt's Interview with Latitudes |
- |
- |
Other |
| Functional Psychiatry |
Greenblatt, James M.D. |
- |
Other |
| Ten Warning Signs of Good Health |
- |
- |
Other |
